{"id":"hmg-ibsa","safety":{"commonSideEffects":[{"rate":"null","effect":"Ovarian hyperstimulation syndrome"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"hMG-IBSA works by stimulating the ovaries to produce eggs, which can then be fertilized. This is achieved through the administration of human menopausal gonadotropin, a hormone that mimics the action of luteinizing hormone and follicle-stimulating hormone. By stimulating ovulation, hMG-IBSA can help women with PCOS or other ovulatory disorders to conceive.","oneSentence":"Human menopausal gonadotropin is used to stimulate ovulation in women with polycystic ovary syndrome (PCOS) or other ovulatory disorders.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:45:05.909Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Induction of ovulation in anovulatory infertile women"}]},"trialDetails":[{"nctId":"NCT03209687","phase":"PHASE4","title":"The Value of Addition of Human Menopausal Gonadotropin Drug Following Oocytes Retrieval in IVF Cycles","status":"COMPLETED","sponsor":"Cairo University","startDate":"2017-07-06","conditions":"Infertility","enrollment":600},{"nctId":"NCT05778331","phase":"","title":"The Difference Between POSEIDON Group 3 and Group 4 as Regards IVF","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2023-01-10","conditions":"Infertility, Female, IVF","enrollment":340},{"nctId":"NCT04870502","phase":"PHASE2, PHASE3","title":"Effect of Ubiquinol Supplementation on Ovulation Induction in Clomiphene Citrate Resistance","status":"COMPLETED","sponsor":"Saudi German Hospital - Madinah","startDate":"2019-04-01","conditions":"Polycystic Ovarian Syndrome","enrollment":161},{"nctId":"NCT03876145","phase":"NA","title":"The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome","status":"COMPLETED","sponsor":"Royan Institute","startDate":"2016-11-12","conditions":"Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome","enrollment":120},{"nctId":"NCT04539613","phase":"","title":"Controlled Ovarian Hyperstimulation (COH) With Sequential HPFSH & HMG Versus Rec-F.S.H Alone in ICSI Cycle","status":"UNKNOWN","sponsor":"Alaa Fouli Gaber Ebrahim","startDate":"2020-09-01","conditions":"Ovarian Stimulation in ICSI","enrollment":100},{"nctId":"NCT03177538","phase":"PHASE4","title":"Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders","status":"COMPLETED","sponsor":"D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology","startDate":"2017-09-04","conditions":"Infertility, Female","enrollment":32},{"nctId":"NCT01577472","phase":"PHASE4","title":"Efficacy Study Comparing the Effect of Clomiphencitrate to an Antagonist Protocol","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2013-08","conditions":"Female Infertility, Ovarian Insufficiency","enrollment":117},{"nctId":"NCT03684824","phase":"NA","title":"Accuracy of Ultrasound Markers Versus Biochemical Markers in Prediction of Ovarian Response in Obese Women Undergoing IVF/ICSI Treatment","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2018-09","conditions":"Invitro Fertilization","enrollment":100},{"nctId":"NCT02737800","phase":"NA","title":"Effect of Prolonged GnRh Agonists on Results of Intracytoplasmic Sperm Injection (ICSI ) in Endometrioma Patients","status":"COMPLETED","sponsor":"Kasr El Aini Hospital","startDate":"2016-04","conditions":"Endometrioma","enrollment":88},{"nctId":"NCT03457233","phase":"NA","title":"The Impact of Body Weight on Reproductive Outcomes in Poor Ovarian Responders in ICSI Cycles","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2015-01-03","conditions":"Invitro Fertilization","enrollment":185},{"nctId":"NCT03398993","phase":"NA","title":"Effect of Endometrial Injury in Couples With Unexplained Infertility","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2018-01","conditions":"Unexplained Infertility","enrollment":100},{"nctId":"NCT02469805","phase":"PHASE3","title":"Stimulated Versus Un-stimulated Intrauterine Insemination Cycles in Couples With Mild Male Factor Infertility","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2015-06","conditions":"Subfertility","enrollment":450},{"nctId":"NCT02338206","phase":"PHASE2","title":"Long Protocol and Growth Hormone in Poor Responders","status":"COMPLETED","sponsor":"Woman's Health University Hospital, Egypt","startDate":"2015-03","conditions":"Infertility","enrollment":240},{"nctId":"NCT02741154","phase":"PHASE4","title":"Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of ICSI","status":"COMPLETED","sponsor":"Minia University","startDate":"2016-08-12","conditions":"Infertility Indicated for ICSI","enrollment":50},{"nctId":"NCT03263299","phase":"PHASE4","title":"Value of Cabergoline and Low Dose Aspirin in Poor Responders Undergoing ICSI-ET With GnRH Agonist Flare-Up-Protocol","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2017-08","conditions":"Invitro Fertilization","enrollment":120},{"nctId":"NCT02470169","phase":"PHASE3","title":"Stimulated Versus Un-stimulated Intrauterine Insemination Cycles in Women With Endometriosis","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2015-06","conditions":"Subfertility","enrollment":450},{"nctId":"NCT02461173","phase":"PHASE3","title":"Stimulated Intrauterine Insemination Cycles and Unstimulated Intrauterine Insemination Cycles in Couples With Unexplained Infertility","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2015-06","conditions":"Infertility","enrollment":450},{"nctId":"NCT01312766","phase":"PHASE3","title":"Safety and Efficacy Study in in Vitro Fertilisation (IVF) Patients","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2011-02","conditions":"Infertility","enrollment":270},{"nctId":"NCT02752568","phase":"NA","title":"Assisted Hatching Versus Endometrial Scratch in Recurrent Implantation Failure","status":"UNKNOWN","sponsor":"Kasr El Aini Hospital","startDate":"2016-05","conditions":"Recurrent Implantation Failure","enrollment":300},{"nctId":"NCT02728440","phase":"","title":"Effects of Gonadotropin Replacement Therapy on Metabolic Parameters in Patients With Hypogonadism","status":"COMPLETED","sponsor":"Gulhane School of Medicine","startDate":"2010-05","conditions":"Idiopathic Hypogonadotropic Hypogonadism","enrollment":30},{"nctId":"NCT02681536","phase":"NA","title":"Miniflare Versus Long Protocol in Poor Responders","status":"UNKNOWN","sponsor":"Woman's Health University Hospital, Egypt","startDate":"2016-02","conditions":"Infertility","enrollment":200},{"nctId":"NCT02673632","phase":"","title":"The Influence of AMH on Ovarian Responsiveness to Ovulation Induction With GnRH in Women With PCOS","status":"UNKNOWN","sponsor":"Ain Shams Maternity Hospital","startDate":"2016-02","conditions":"Infertility","enrollment":30},{"nctId":"NCT02640976","phase":"EARLY_PHASE1","title":"Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program","status":"COMPLETED","sponsor":"Cairo University","startDate":"2013-06","conditions":"Infertility","enrollment":216},{"nctId":"NCT01897324","phase":"PHASE4","title":"IVF/ICSI Protocols in Poor Responders With Growth Hormone","status":"COMPLETED","sponsor":"Woman's Health University Hospital, Egypt","startDate":"2013-07","conditions":"Female Infertility Due to Diminished Ovarian Reserve","enrollment":287},{"nctId":"NCT02185326","phase":"PHASE4","title":"Microflare Protocol in Poor Responders","status":"COMPLETED","sponsor":"Woman's Health University Hospital, Egypt","startDate":"2014-07","conditions":"Female Infertility Due to Diminished Ovarian Reserve","enrollment":145},{"nctId":"NCT00823004","phase":"PHASE1, PHASE2","title":"Antagonist/Letrozole in Poor Responders","status":"COMPLETED","sponsor":"Yazd Research & Clinical Center for Infertility","startDate":"2008-06","conditions":"Ovarian Stimulation","enrollment":120},{"nctId":"NCT00335894","phase":"PHASE3","title":"Clinical Study of Clinical Efficacy and Tolerability of hMG-IBSA s.c.in Women Undergoing COH in an ART Programme (IVF).","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2005-05","conditions":"Infertility","enrollment":144},{"nctId":"NCT00464607","phase":"PHASE3","title":"Prospective, Randomized, Controlled, Clinical Study on Tolerability and Efficacy of hMG-IBSA","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2001-12","conditions":"Infertility","enrollment":160}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"hMG-IBSA","genericName":"hMG-IBSA","companyName":"IBSA Institut Biochimique SA","companyId":"ibsa-institut-biochimique-sa","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Human menopausal gonadotropin is used to stimulate ovulation in women with polycystic ovary syndrome (PCOS) or other ovulatory disorders. Used for Induction of ovulation in anovulatory infertile women.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}